APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Sickle Cell Anemia Therapeutics

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).

Types
Blood Transfusion · Pharmacotherapy · Bone Marrow Transplant
Applications
Child · Adult

5 editions21 December 2025

View 5 research editions

Pharma & Healthcare

Renin-Inhibitors

Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and…

Types
150mg/Tablet · 300mg/Tablet
Applications
Age below 45 · Age 45-55 · Age 55-65

5 editions21 December 2025

View 5 research editions
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: Renin-InhibitorsCompare research options for Renin-Inhibitors
APO Research, Inc.